newsfilter
← Latest News
GlobeNewswire·

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

Decoy's proprietary IMP3ACT™ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools Decoy is leveraging non-dilutive funding and